Gts Securities LLC Assertio Holdings, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$1.07 - $1.75 $20,116 - $32,900	18,800 Added 56.97%	51,800 $61,000
Q2 2024 Aug 14, 2024	BUY	$0.75 - $1.31 $11,550 - $20,174	15,400 Added 87.5%	33,000 $40,000
Q1 2024 May 15, 2024	SELL	$0.79 - $1.14 $13,157 - $18,986	-16,655 Reduced 48.62%	17,600 $16,000
Q4 2023 Feb 14, 2024	BUY	$1.02 - $2.57 $1,002 - $2,526	983 Added 2.95%	34,255 $36,000
Q3 2023 Nov 15, 2023	BUY	$2.52 - $5.69 $83,845 - $189,317	33,272 New	33,272 $85,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.